What is the primary therapeutic goal of antilipemic therapy?

What is the primary therapeutic goal of antilipemic therapy?

• A. To lower the serum low-density lipoprotein (LDL) cholesterol levels
• B. To lower the serum high-density lipoprotein (HDL) cholesterol levels
• C. To raise the serum LDL cholesterol levels
• D. To raise the serum HDL cholesterol levels

Answer: (A)

Lowering LDL cholesterol is the main goal of antilipemic therapy. LDL particles deliver cholesterol to arterial walls, promoting plaque buildup, atherosclerosis, and higher risk of heart attack and stroke. Reducing LDL reduces the amount of cholesterol available to form that plaque, which is why lipid-lowering medications are chosen and titrated to lower LDL most effectively. Statins, for example, cut cholesterol synthesis in the liver and increase LDL receptor activity, pulling more LDL out of the bloodstream. While raising HDL or lowering triglycerides can provide additional benefit, they are not the primary target, and raising HDL alone hasn’t shown the same consistent cardiovascular risk reduction as lowering LDL. So the best answer is to lower serum LDL cholesterol levels.

Lowering LDL cholesterol is the main goal of antilipemic therapy. LDL particles deliver cholesterol to arterial walls, promoting plaque buildup, atherosclerosis, and higher risk of heart attack and stroke. Reducing LDL reduces the amount of cholesterol available to form that plaque, which is why lipid-lowering medications are chosen and titrated to lower LDL most effectively. Statins, for example, cut cholesterol synthesis in the liver and increase LDL receptor activity, pulling more LDL out of the bloodstream. While raising HDL or lowering triglycerides can provide additional benefit, they are not the primary target, and raising HDL alone hasn’t shown the same consistent cardiovascular risk reduction as lowering LDL. So the best answer is to lower serum LDL cholesterol levels.